NCT06070610View on ClinicalTrials.gov

A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Nintedanib and Pirfenidone in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 8, 2023

Primary Completion Date

December 14, 2023

Study Completion Date

December 14, 2023

Conditions
Healthy
Interventions
DRUG

BI 1015550

BI 1015550

DRUG

Nintedanib

Soft capsules

DRUG

Pirfenidone

Film-coated tablets

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06070610 - A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Nintedanib and Pirfenidone in the Blood | Biotech Hunter | Biotech Hunter